Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
vlag Reata Pharmaceuticals Inc 25/09 172,360 USD
+0,02% 		+0,02%
vlag Redhill Biopharma 20:18 0,474 USD
+0,15% 		+0,15%
vlag Regeneron Pharmaceuticals, Inc. 20:35 983,100 USD
+0,08% 		+0,08%
vlag Regulus Therapeutics Inc 20:35 2,065 USD
+3,25% 		+3,25%
vlag Repare Therapeutics Inc 20:19 3,510 USD
-1,13% 		-1,13%
vlag Revance Therapeutics Inc 20:35 3,150 USD
+4,30% 		+4,30%
vlag Rhythm Pharmaceuticals Inc. 20:35 38,410 USD
+1,19% 		+1,19%
vlag Rigel Pharmaceuticals 20:33 0,956 USD
+0,57% 		+0,57%
vlag Rocket Pharmaceuticals Inc 20:35 23,070 USD
+1,99% 		+1,99%

Nieuws over “Fabricage van farmaceutische preparaten”

20:15 · Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM · Persbericht

20:15 · Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM · Persbericht

14:30 · Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine · Persbericht

13:30 · Soligenix Encourages Stockholders to Vote Prior to Annual Meeting · Persbericht

13:00 · PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation · Persbericht

17/05 · BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification · Persbericht

17/05 · AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® · Persbericht

17/05 · Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

17/05 · AKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc. · Persbericht

16/05 · Galapagos creates new subscription right plans · Persbericht

16/05 · Galapagos creëert nieuwe inschrijvingsrechtenplannen · Persbericht

16/05 · Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress · Persbericht

16/05 · Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer · Persbericht

16/05 · Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis · Persbericht

16/05 · Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice · Persbericht

16/05 · Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte · Persbericht

16/05 · Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome · Persbericht

16/05 · With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin · Persbericht

15/05 · Galapagos gaat kankertherapie produceren in Amerikaanse bloedcentra · Tijd.be (€)

Het beursgenoteerde Mechelse biotechbedrijf Galapagos gaat samenwerken met Blood Centers of America, het grootste Amerikaanse bloedvoorzieningsnetwerk, om er lokaal zijn gepersonaliseerde kankerbehand...

15/05 · Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors · Persbericht

15/05 · Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S. · Persbericht

Mijn selecties